⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
globenewswire.com
QNTM
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
globenewswire.com
QNTM
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
globenewswire.com
QNTM
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
globenewswire.com
QNTM
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
globenewswire.com
QNTM
Distinguished Housing Finance Executive Michael G. Bradley Appointed Board Advisor at Quantarium
accessnewswire.com
FMCC
CLGX
QNTM
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
globenewswire.com
QNTM
Quantum BioPharma Ltd. Provides Corporate Update
globenewswire.com
QNTM
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication
globenewswire.com
QNTM
Three Biotech Companies Redefining Value Creation Through Dual Strategies
accessnewswire.com
MDCX
COEP
QNTM